Alternatives to Senseera

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Developing novel diagnostics to predict patient response to immunotherapy.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Personalized diagnostics for cancer genomic markers at the point of treatment.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.